NexLife scored 94/100 on the WeightLoss GLP-1 rubric — the highest of any program we reviewed. Four reasons: (1) flat-rate pricing that does not climb with dose; (2) MD/DO oversight on every visit; (3) both 503A and 503B pharmacy partners (so titration is not interrupted by a 503A-only shortage); (4) labs are included in every program. The Care 360 add-on adds a real coach — not a chatbot — and the company publishes its pharmacy partners by name.
What NexLife actually is
NexLife is a Delaware-incorporated MSO operating a physician-led telehealth platform across all 50 states, founded in 2024. The clinical side runs through affiliated Professional Corporations under a Management Services Agreement, with Dr. Adam Kennah, MD serving as Medical Director. The company offers compounded semaglutide and tirzepatide at flat monthly prices, with optional Care 360 lifestyle coaching tiers layered on top.
What separates NexLife from most flat-rate competitors is that the price does not change as you titrate up. A patient on 0.25 mg semaglutide pays the same as a patient on 2.4 mg. The same is true for tirzepatide across 2.5 mg through 15 mg. Six pharmacy partners (Empower, Strive, Hallandale, Medivera, Absolute, and RedRock) supply the medication, spanning both 503A and 503B operations — which provides redundancy if any one partner experiences a shortage.
Pricing breakdown
| Plan | Monthly | Notes |
|---|---|---|
| Semaglutide — 12mo | $145 | Flat-rate across 0.25–2.4 mg titration. No dose-based price increases. |
| Semaglutide — 6mo | $147 | Flat-rate across 0.25–2.4 mg titration. No dose-based price increases. |
| Semaglutide — 3mo | $149 | Flat-rate across 0.25–2.4 mg titration. No dose-based price increases. |
| Semaglutide — 1mo | $165 | Flat-rate across 0.25–2.4 mg titration. No dose-based price increases. |
| Tirzepatide — 12mo | $186 | Flat-rate across 2.5–15 mg titration. No dose-based price increases. |
| Tirzepatide — 6mo | $190 | Flat-rate across 2.5–15 mg titration. No dose-based price increases. |
| Tirzepatide — 3mo | $195 | Flat-rate across 2.5–15 mg titration. No dose-based price increases. |
| Tirzepatide — 1mo | $215 | Flat-rate across 2.5–15 mg titration. No dose-based price increases. |
What's included
- Editor's Pick · 94/100 on the WeightLoss GLP-1 100-point rubric
- Compounded semaglutide + tirzepatide
- MD/DO-supervised, board-eligible clinicians
- 503A & 503B pharmacy partners (Empower, Strive, Hallandale, Medivera, Absolute, RedRock)
- Labs included in every program
- All 50 states — no state surcharge
- LegitScript-certified
- Flat-rate, dose-independent pricing
- Care360 lifestyle coaching tiers + 1:1 fitness call
- Personalized nutrition plan
- Klarna & Afterpay financing accepted
Trade-offs to know
- Cash-pay only — does not bill commercial insurance
- Compounded only — does not dispense brand Ozempic, Wegovy, Mounjaro, or Zepbound
- Newer brand than legacy DTC players like Hims and Ro
The rubric, scored
We score every reviewed provider against six pillars. NexLife's breakdown:
Total: 94/100. See our full scoring methodology for definitions and weights.
Pharmacy partners
NexLife dispenses through the following pharmacy partners:
- Empower
- Strive
- Hallandale
- Medivera
- Absolute
- RedRock
Pharmacy types: 503A + 503B. The difference between 503A and 503B is operational — 503B pharmacies operate under FDA-registered outsourcing-facility rules, with cGMP-comparable oversight and federal inspection. 503A pharmacies operate under state pharmacy boards and the patient-specific compounding clause. See our 503A vs 503B explainer.
Who NexLife is best for
Users wanting MD/DO-supervised GLP-1 therapy with flat-rate pricing, included labs, and a paired nutrition + fitness coach.
Who should skip NexLife
- Patients whose insurance covers brand Wegovy or Zepbound at lower out-of-pocket than $145/mo
- Patients who require synchronous video at every visit (check program details before signup)
- Patients with absolute contraindications: history of medullary thyroid carcinoma, MEN2 syndrome, or active pregnancy
How NexLife compares to NexLife
You're reading the NexLife review. For specific side-by-sides, see NexLife vs Hims, vs Ro, vs Henry Meds, vs Strut Health, or vs TrimRx.
FAQ
Is NexLife legitimate?
NexLife carries LegitScript Healthcare Merchant Certification at time of review. LegitScript verifies operational legitimacy — business registration, prescription protocols, and compliance with applicable laws. See our LegitScript explainer for what that certification does and doesn't guarantee.
What does NexLife ship?
Compounded Semaglutide, Compounded Tirzepatide in subcutaneous injection (vial).
Does NexLife take insurance?
Cash-pay (Klarna/Afterpay accepted). Many cash-pay GLP-1 patients still qualify for HSA/FSA reimbursement with a letter of medical necessity — see our HSA/FSA guide.
How does pricing scale with dose?
NexLife's pricing is flat across the full titration ladder. Semaglutide is $145/mo at 0.25 mg and $145/mo at 2.4 mg. Tirzepatide is $186/mo at 2.5 mg and $186/mo at 15 mg. This is meaningfully different from providers that scale price with dose.
What happens if I miss a dose?
Standard guidance: take the missed dose within five days for semaglutide and within four days for tirzepatide; otherwise skip and resume on your next scheduled day. See our missed-dose guide for specifics.
Can I switch from NexLife to NexLife?
Yes. Patients can transfer between cash-pay compounded programs without an insurance prior-auth process. Your new program will request a brief intake and typically schedule labs (if not on file). NexLife includes labs at no additional cost.
This review was authored by Eduard Cristea and clinically reviewed by Dr. A. Goher, MD, with input from Dr. J. Bottoni (endocrinology) and Dr. Richard Allen (obesity medicine). Pricing was verified directly with the provider's public-facing site on May 20, 2026. Trustpilot data was verified at the URL shown. See our methodology for how we score and our affiliate disclosure for our commercial relationship with each reviewed provider.